Literature DB >> 28122873

Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology Laboratory.

Daniel J Diekema1.   

Abstract

Health care-associated infection (HAI) rates are subject to public reporting and are linked to hospital reimbursement from the Centers for Medicare and Medicaid Services (CMS). The increasing pressure to lower HAI rates comes at a time when advances in the clinical microbiology laboratory (CML) provide more-precise and -sensitive tests, altering HAI detection in ways that may increase reported HAI rates. I review how changing CML practices can impact HAI rates and how the financial implications of HAI metrics may produce pressure to change diagnostic testing practices. Finally, I provide suggestions for how to respond to this rapidly changing environment.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  clinical microbiology; health care-associated infections; infection prevention; nosocomial; pay for performance

Mesh:

Year:  2017        PMID: 28122873      PMCID: PMC5377856          DOI: 10.1128/JCM.02544-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

2.  Gut check: Clostridium difficile testing and treatment in the molecular testing era.

Authors:  Whitney R Buckel; Edina Avdic; Karen C Carroll; Vidhya Gunaseelan; Eric Hadhazy; Sara E Cosgrove
Journal:  Infect Control Hosp Epidemiol       Date:  2015-02       Impact factor: 3.254

3.  When counting central line infections counts.

Authors:  Mary Dixon-Woods; Eli N Perencevich
Journal:  Infect Control Hosp Epidemiol       Date:  2013-04-18       Impact factor: 3.254

4.  Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.

Authors:  Rebekah W Moehring; Eric T Lofgren; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-29       Impact factor: 3.254

5.  The harder you look, the more you find: Catheter-associated bloodstream infection surveillance variability.

Authors:  Matthew F Niedner
Journal:  Am J Infect Control       Date:  2010-10       Impact factor: 2.918

6.  Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.

Authors:  Hoonmo L Koo; John N Van; Meina Zhao; Xunyan Ye; Paula A Revell; Zhi-Dong Jiang; Carolyn Z Grimes; Diana C Koo; Todd Lasco; Claudia A Kozinetz; Kevin W Garey; Herbert L DuPont
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04-22       Impact factor: 3.254

7.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Authors:  Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

8.  Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter-Associated Asymptomatic Bacteriuria.

Authors:  Barbara W Trautner; Larissa Grigoryan; Nancy J Petersen; Sylvia Hysong; Jose Cadena; Jan E Patterson; Aanand D Naik
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

9.  Hospital Characteristics Associated With Penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program.

Authors:  Ravi Rajaram; Jeanette W Chung; Christine V Kinnier; Cynthia Barnard; Sanjay Mohanty; Emily S Pavey; Megan C McHugh; Karl Y Bilimoria
Journal:  JAMA       Date:  2015-07-28       Impact factor: 56.272

10.  Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee.

Authors:  Thomas R Talbot; Dale W Bratzler; Ruth M Carrico; Daniel J Diekema; Mary K Hayden; Susan S Huang; Deborah S Yokoe; Neil O Fishman
Journal:  Ann Intern Med       Date:  2013-11-05       Impact factor: 25.391

View more
  3 in total

Review 1.  Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem

Authors:  Gary V Doern; Karen C Carroll; Daniel J Diekema; Kevin W Garey; Mark E Rupp; Melvin P Weinstein; Daniel J Sexton
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

2.  The Need for Dedicated Microbiology Leadership in the Clinical Microbiology Laboratory.

Authors:  Linoj P Samuel; Glen T Hansen; Colleen S Kraft; Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

3.  Identification of Clostridium difficile Asymptomatic Carriers in a Tertiary Care Hospital.

Authors:  André Luiz de Oliveira Silva; Alexandre R Marra; Marinês Dalla Valle Martino; Ana Carolina Cintra Nunes Mafra; Michael B Edmond; Oscar Fernando Pavao Dos Santos
Journal:  Biomed Res Int       Date:  2017-10-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.